Dexrazoxane
Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a609010 |
License data |
|
Intravenous | |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.[1]
Uses
Dexrazoxane has been used to protect the
Dexrazoxane was designated by the US FDA as an orphan drug for "prevention of cardiomyopathy for children and adults 0 through 16 years of age treated with anthracyclines".[7] This decision allows virtually all children to receive dexrazoxane starting with the first dose of anthracycline at the discretion of the treating provider. The label change by the agency announcing dexrazoxane as an approved cardio-oncology protectant has been followed by a review by the agency.[8] Currently, the only FDA and EMA approved cardioprotective treatment for anthracycline cardioprotection is dexrazoxane, which provides effective primary cardioprotection against anthracycline-induced cardiotoxicity without reducing anthracycline activity and without enhancing secondary malignancies.[9]
The United States
Mechanism
As a derivative of
References
- ^ "Zinecard (Dexrazoxane): Side Effects, Interactions, Warning, Dosage & Uses".
- PMID 15247354.
- S2CID 20119026.
- PMID 17290056.
- PMID 20016527.
- ^ "FDA Statement on Dexrazoxane". Food and Drug Administration. Archived by the Wayback Machine. 20 July 2011. Archived from the original on 18 August 2011. Retrieved 29 October 2023.
- ^ "Orphan drug designations and approvals". Retrieved June 7, 2019.
- ^ "Cardioxane". 2018-09-17.
- PMID 29747541.
- ^ "NDA 22-025 TOTECT™ (DEXRAZOXANE) FOR INJECTION | Totect™ Package Insert" (PDF). FDA. Archived by the Wayback Machine. Archived from the original (PDF) on 25 March 2009. Retrieved 29 October 2023.
- S2CID 7753443.
- S2CID 25950994.
- ^ "ZINECARD- dexrazoxane hydrochloride injection, powder, lyophilized, for solution". Pharmacia and Upjohn Company LLC.
- PMID 9990337.